GlassScriptPhysician profile
Laura A Falco
NPI 1396819132
$3,455.91
in general payments reported to CMS, 2019-2025
17 companies · $1,059 in 2025
The $1,059 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $152 · 2021: $293 · 2022: $166 · 2023: $378 · 2024: $576 · 2025: $1,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.14 |
| Travel and Lodging | $620.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,168.66 | 2021-2025 | Precision 1, Total30, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $280.11 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $273.95 | 2022-2024 | Miebo, Xiidra, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $230.68 | 2019-2021 | |
| Coopervision INC. | $204.18 | 2019-2023 | Onefit Contact Lens, Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $176.46 | 2024-2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $174.50 | 2019-2021 | |
| Genentech USA, INC. | $136.56 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $130.98 | 2024 | Eylea Hd |
| Aerie Pharmaceuticals, INC. | $118.41 | 2019 | |
| Shire North American Group INC | $104.32 | 2019 | |
| Abbvie INC. | $101.03 | 2022 | |
| Mallinckrodt Hospital Products INC. | $98.21 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $92.97 | 2025 | |
| Johnson & Johnson Surgical Vision, INC. | $74.45 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $74.07 | 2020 | |
| Horizon Therapeutics Plc | $16.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Falco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.